Literature DB >> 23224742

Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT study: reply to comment by Erro et al.

Daniela Di Giuda, Giovanni Camardese, Fabrizio Cocciolillo, Alfonso Fasano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23224742     DOI： 10.1007/s00259-012-2303-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  9 in total

1.  Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease.

Authors:  U Müller; T Wächter; H Barthel; M Reuter; D Y von Cramon
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

2.  Depression rating scales in Parkinson's disease: critique and recommendations.

Authors:  Anette Schrag; Paolo Barone; Richard G Brown; Albert F G Leentjens; William M McDonald; Sergio Starkstein; Daniel Weintraub; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

3.  Anxiety rating scales in Parkinson's disease: critique and recommendations.

Authors:  Albert F G Leentjens; Kathy Dujardin; Laura Marsh; Pablo Martinez-Martin; Irene H Richard; Sergio E Starkstein; Daniel Weintraub; Christina Sampaio; Werner Poewe; Oliver Rascol; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2008-10-30       Impact factor: 10.338

4.  Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.

Authors:  Daniela Di Giuda; Giovanni Camardese; Anna Rita Bentivoglio; Fabrizio Cocciolillo; Arianna Guidubaldi; Lorella Pucci; Isabella Bruno; Luigi Janiri; Alessandro Giordano; Alfonso Fasano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-14       Impact factor: 9.236

5.  Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale.

Authors:  Albert F G Leentjens; Kathy Dujardin; Laura Marsh; Irene H Richard; Sergio E Starkstein; Pablo Martinez-Martin
Journal:  Mov Disord       Date:  2011-03-07       Impact factor: 10.338

6.  Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.

Authors:  Daniel Weintraub; Andrew B Newberg; Mark S Cary; Andrew D Siderowf; Paul J Moberg; Galit Kleiner-Fisman; John E Duda; Matthew B Stern; David Mozley; Ira R Katz
Journal:  J Nucl Med       Date:  2005-02       Impact factor: 10.057

7.  Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.

Authors:  Roberto Erro; Sabina Pappatà; Paolo Barone; Maria Teresa Pellecchia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-07       Impact factor: 9.236

8.  Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.

Authors:  Irena Rektorova; Hana Srovnalova; Radka Kubikova; Jiri Prasek
Journal:  Mov Disord       Date:  2008-08-15       Impact factor: 10.338

9.  Parkinson's disease motor subtypes and mood.

Authors:  David J Burn; Sabine Landau; John V Hindle; Michael Samuel; Kenneth C Wilson; Catherine S Hurt; Richard G Brown
Journal:  Mov Disord       Date:  2011-12-11       Impact factor: 10.338
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.